Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Oncolytic-virus-therapy

 Probe for electrofusion, electroporation, or like procedure
The present invention provides a structure and method for treating samples in a well tray. Briefly, ...


 Device and method for the electrophoretic separation of macromolecules
The invention relates to an electrophoresis device and an electrophoresis method for the separation ...


 Superfusion apparatus
It is an object of the present invention to provide a superfusion apparatus for use in receptor ...


 Method and apparatus for administration of anticoagulant to red cell suspension output of a blood separator
OF THE PREFERRED EMBODIMENTS Referring now to the drawings, particularly to FIG. 1, there is ...


 Electroporation device
I claim: 1. An electroporation apparatus for electroporating living cells with molecules comprising:...


 Implantable electroporation method and apparatus for drug and gene delivery
Accordingly, it is the primary object of the present invention to provide an improved method of ...


 Flow electroporation chamber with electrodes having a crystalline metal nitride coating
The present invention provides improved electrodes for use in generating an electrical field in a ...


 Solely pollen-specific promoter
What is claimed is: 1. An isolated solely pollen-specific promoter derived from Arabidopsis ...


 Gene transfer using transformed, neodetermined, embryonic cells
This invention relates to the preparation of carrier cells capable of delivering genetic material ...


 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
The present invention provides methods and compositions for inhibiting loss of bone mass, and/or ...


 Oncolytic virus therapy

Details
Inventors: Groene, William S.; Miller, Jeffrey A.; Mueller, Stephen N.;
Assignee: Wellstat Biologics Corporation (Gaithersburg, MD)
Primary Examiner: Canella; Karen A.
Assistant Examiner:
Attorney, Agent or Firm: Kreisler; Lewis J.

A method of treating a human subject with cancer is disclosed. A pharmaceutical composition is administered to the subject, the pharmaceutical composition comprising human leukocytes and a replication-competent oncolytic virus in suspension in a physiologically acceptable solution. Alternatively the pharmaceutical composition comprises human leukocytes or platelets infected with an oncolytic virus.

DETAILED DESCRIPTION OF THE INVENTION As used herein the term "human cells" means cells isolated from a human, or cultured cells that have been derived from cells isolated from a human and/or whose nucleic acid component has been altered by, for example, immortalization, irradiation or recombinant means.
"Human leukocytes" and "human platelets" are human cells that are leukocytes and platelets, respectively.
Except where otherwise specified or required by the context the terms "cells" or "human cells" refer to leukocytes and/or platelets.
As used herein the term "plaque-forming unit" (pfu) means one infectious virus particle.
As used herein the term "multiplicity of infection" (MOI) means the number of infectious virus particles added per cell.
As used herein the term "clonal virus" means a virus derived from a single infectious virus particle and for which individual molecular clones have significant nucleic acid sequence homology.
For example, the sequence homology is such that at least eight individual molecular clones from the population of virions have a sequence homology greater than 95% over 300 contiguous nucleotides.
As used herein the term "leukocyte virus complex" (LVC) means the complex formed when an oncolytic virus is mixed with a leukocyte cell population and the virus has become associated with the cells.
The term includes both cells where the virus is bound to the outside of the cell and cells which are infected by the virus.
As used herein a virus is said to "bind(s) specifically" to a given cell if such virus binds to such cell with a greater specificity than such virus binds to erythrocytes.
The terms bind(s) specifically and specifically bind(s) are used interchangeably.
As used herein "NDV" is an abbreviation for Newcastle Disease Virus.
As used herein the term "replication-competent" virus refers to a virus that produces infectious progeny in cancer cells.
As used herein the transitional term "comprising" is open-ended.
A claim utilizing this term can contain elements in addition to those recited in such claim



Related patents
  Covalently cross-linked oligonucleotides
OF THE INVENTION In accordance with the objects of this invention novel, covalently cross-linked oligonucleotide strands are disclosed. Preferably such strands are "...
  Methods of inducing cancer cell death and tumor regression
The present invention provides methods of treating cancer in a patient (e.g., a mammal such as a human) in need of such treatment, comprising administering an effective ...
  Injectable hyaluronic acid derivative with pharmaceuticals/cells
OF THE INVENTION The present invention concerns injectable, biocompatible and biodegradable compositions containing at least one hyaluronic acid benzyl ester derivative ...
  Modification of polymer surfaces and molecular immobilization by photoreaction
OF THE INVENTION To obviate disadvantages associated with the modification methods presently existing, the object of the present invention is to provide a method for ...
  Wound and skin care compositions
What is claimed: 1. A composition comprising a dermatologically acceptable carrier and an effective amount of a hydroxy acid compound, present in a concentration of ...
  Water treatment apparatus
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. Water purification apparatus for purifying dirty water,...
  Membrane cell
What we claim is: 1. A monopolar filter press electrolytic cell suitable for use in the electrolysis of an aqueous alkali metal halide solution (brine) to produce an ...
  Encapsulating biological active substances into erythrocytes
We claim: 1. A process for the encapsulation in human or animal erythrocytes of at least one substance having a biological activity utilizing a dialysis element having a ...
  Flow chamber and electro-manipulator incorporating same
Accordingly, an object of the present invention is to provide a flow chamber and an electro-manipulator incorporating the same which can be operated easily, and which ...
  Electroblotting technique for transferring specimens from a polyacrylamide electrophoresis or like gel onto a membrane
What is claimed is: 1. An apparatus especially suitable for transferring a biological specimen from a polyacrylamide electrophoresis or like gel onto a support sheet by ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved